Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

217 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT03205358

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Number 005 Espoo, Finland
  • Investigational Site Number 006 Helsinki, Finland
  • Investigational Site Number 002 Helsinki, Finland
  • Investigational Site Number 007 Jarvenpaa, Finland
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

NCT02199691

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham, Alabama, United States
  • Huntsville, Alabama, United States
  • Downey, California, United States
  • San Diego, California, United States
View all 36 locations
View Trial Details
Completed

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

NCT03077438

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Dothan, Alabama, United States
  • Investigational Site Tucson, Arizona, United States
  • Investigational Site Jonesboro, Arkansas, United States
View all 36 locations
View Trial Details
Completed

Adolescent MenACWY Booster Study

NCT03694405

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Children's Hospital Research Institute, University of Calgary Calgary, Alberta, Canada
  • Vaccine Evaluation Center, BC Children's Hospital Research Institute Vancouver, British Columbia, Canada
  • Canadian Center for Vaccinology Halifax, Nova Scotia, Canada
View Trial Details
Completed

Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine

NCT01939158

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • The Childrens Hospital at Westmead Westmead, New South Wales, Australia
  • Women's and Children's Hospital North Adelaide, South Australia, Australia
  • Vaccine and Immunization Research Group Melbourne, Victoria, Australia
View all 51 locations
View Trial Details
Completed

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

NCT00955682

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 14 locations
View Trial Details
Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

NCT03433482

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Salvador, Estado de Bahia, Brazil
  • GSK Investigational Site Natal, Rio Grande do Norte, Brazil
  • GSK Investigational Site Rio de Janeiro, Brazil
  • GSK Investigational Site São Paulo, Brazil
View all 49 locations
View Trial Details

Related conditions